The House of Representatives just passed a resolution condemning the “horrors of socialism” by a 285 to 98 margin. All the no votes were cast by Democrats indicating that a majority of the members ...

The Trump administration has done a good job with promoting a free-market approach in many of its policies. However, they have taken a completely different tact to reduce prescription drug prices in ...

"Government intervention can cut costs in the moment," writes healthcare policy expert Sally Pipes. "But it does so at the expense of future treatments and cures." The Democrats' days in control of ...

Health and Human Services Secretary Robert F. Kennedy Jr., at a White House event to announce President Trump’s new prescription-drug-pricing executive order, said he had a “couple of kids who are ...

For decades, America’s drug-price debate has centered on a fundamental tension: How do policymakers encourage expensive research and development, while ensuring that companies keep final prices ...

As Robert L. Schuettinger documents in Forty Centuries of Wage and Price Controls: How Not to Fight Inflation, attempts to cap prices stretch back thousands of years. The results have been bleak. From ...

“The two big problems facing the pharmaceutical industry are price controls and an exaggerated incentive to abandon small molecule drugs in favor of biologics.” Over the last several years the ...

Market-distorting price controls are bad enough. But when what’s being controlled are medicines that save and enhance lives, they’re far worse. A true shame, then, that a White House supposedly ...

Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay ...

In the February/March 2026 issue of Reason, we explore Mayor-elect Zohran Mamdani's policy goals and what they mean for New York City. Click here to read the other entries. Zohran Mamdani's campaign ...

The Trump administration is increasingly using government intervention to manage the economy, a shift described as moving from an "invisible hand to visible fist," according to BofA strategist Michael ...